Concepedia

Ma Shenglin

MS

3

Publications

48

Citations

3

H-Index

2011

Active since

Affiliations

Wenzhou Medical University(Current)

Ma Shenglin is an author at Wenzhou Medical University specializing in tumor biology, cancer therapeutics, and surgical oncology.

Top concepts

MedicineOncologyPathologyLung CancerTumor BiologyCancer TherapyCancer ResearchClinical OncologySurgical OncologyMolecular Oncology

Publications per year

2011–2021

3

Publications

3

Efficacy, tolerability, and biomarker analyses from a phase III, randomized, placebo-controlled, parallel group study of gefitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) (INFORM; C-TONG 0804).

L. Zhang, Ma Shenglin, Xianmin Song et al. · Journal of Clinical Oncology · 2011 · 26 citations

Surgical Oncology, Cancer Management, Pathology +17

Clinical study of cisplatin hyperthermic intraperitoneal perfusion chemotherapy in combination with docetaxel, 5-flourouracil and leucovorin intravenous chemotherapy for the treatment of advanced-stage gastric carcinoma.

Zhibing Wu, Deng Qing-hua, Ma Shenglin et al. · PubMed · 2014 · 11 citations

Thoracic radiotherapy and concurrent almonertinib for unresectable stage III EGFR-mutated non-small-cell lung cancer: a phase 2 study

Lucheng Zhu, Changlin Zou, Zhanchun Zhang et al. · BMC Cancer · 2021 · 11 citations · Full text

Rows per page

1–3 of 3